ICRF Monthly Newsletter – September 2018
September 30, 2018 9:27 am
A promising cure for acute leukemia may be within reach thanks to an ICRF Toronto funded scientist
Hebrew University drug trials show 50% cure rate in lab mice; BioTheryX buys rights to the drug candidate for further development and testing. Prof. Yinon Ben-Neriah and his research team at the Hebrew University of Jerusalem’s Faculty of Medicine have developed a new biological drug showing a cure rate of 50 percent for lab mice with acute myeloid leukemia — one of the most aggressive cancers.
Humans of ICRF: Judy Michaelov
“I am a survivor, I am a mother, I am a wife and I am a sister. I was diagnosed with Breast Cancer at the age of 51, but that does not define me. I kicked cancer to the curb. I survived. Family and friends were key during my diagnosis, treatment and recovery, they are my everything. My mother even flew in from Israel to be by side during radiation and made me my favorite soups. I smile everyday, take life one moment at a time and don’t sweat the small stuff…”
A message from Jennifer Ouaknine, ICRF’s Executive Director
L’Shanah Tovah and Chag Sameach – To each person reading this newsletter,
let me wish you a joyous, happy and healthy 5779.
May your year ahead be successful and full of amazing moments!
The 29th Annual George Knudson Oakdale Pro-Am
Thank you to all involved and for your unwavering commitment to ICRF!
UPCOMING EVENTS
ICRF’s Bike for the Fight
October 21st, 2018, 11:30am
CYCLE SLOT #1 SOLD OUT!!
Limited spots available for the second cycle class & Pilates.
Join us for the 2018 Bike for the Fight, an infused spinning + Pilates event where participants and teams will push their limits in the fight against cancer.
ICRF’s Presents – The Greatest Show
ICRF Presents The Greatest Show will take you on a musical journey through some of the smash hit songs from some of the greatest Broadway shows ever! Live vocal performances by outstanding professional and amateur talent from Toronto’s musical theater community.
Categorised in: ICRF Blog